KR20040015821A - 인자 ⅶ 폴리펩티드와 인자 ⅹⅰ폴리펩티드를 포함하는약학적 조성물 - Google Patents

인자 ⅶ 폴리펩티드와 인자 ⅹⅰ폴리펩티드를 포함하는약학적 조성물 Download PDF

Info

Publication number
KR20040015821A
KR20040015821A KR10-2004-7000911A KR20047000911A KR20040015821A KR 20040015821 A KR20040015821 A KR 20040015821A KR 20047000911 A KR20047000911 A KR 20047000911A KR 20040015821 A KR20040015821 A KR 20040015821A
Authority
KR
South Korea
Prior art keywords
factor
related polypeptide
vii
factor vii
coagulation
Prior art date
Application number
KR10-2004-7000911A
Other languages
English (en)
Korean (ko)
Inventor
뢰즈크재르라스머스
Original Assignee
노보 노르디스크 헬스 케어 악티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 노보 노르디스크 헬스 케어 악티엔게젤샤프트 filed Critical 노보 노르디스크 헬스 케어 악티엔게젤샤프트
Publication of KR20040015821A publication Critical patent/KR20040015821A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
KR10-2004-7000911A 2001-07-20 2002-07-19 인자 ⅶ 폴리펩티드와 인자 ⅹⅰ폴리펩티드를 포함하는약학적 조성물 KR20040015821A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200101127 2001-07-20
DKPA200101127 2001-07-20
PCT/DK2002/000505 WO2003007983A1 (en) 2001-07-20 2002-07-19 Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides

Publications (1)

Publication Number Publication Date
KR20040015821A true KR20040015821A (ko) 2004-02-19

Family

ID=8160632

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2004-7000911A KR20040015821A (ko) 2001-07-20 2002-07-19 인자 ⅶ 폴리펩티드와 인자 ⅹⅰ폴리펩티드를 포함하는약학적 조성물

Country Status (16)

Country Link
EP (1) EP1411973A1 (zh)
JP (1) JP2004534855A (zh)
KR (1) KR20040015821A (zh)
CN (1) CN1304050C (zh)
AU (1) AU2002354846B2 (zh)
BR (1) BR0211256A (zh)
CA (1) CA2452677A1 (zh)
CZ (1) CZ200439A3 (zh)
HU (1) HUP0400976A3 (zh)
IL (1) IL159622A0 (zh)
MX (1) MXPA04000415A (zh)
NO (1) NO20040235L (zh)
PL (1) PL369077A1 (zh)
RU (1) RU2298416C2 (zh)
WO (1) WO2003007983A1 (zh)
ZA (1) ZA200400012B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0302052A3 (en) 1999-07-14 2005-12-28 Novo Nordisk Healthcare Ag Use of fviia or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
CN101870729A (zh) 2003-09-09 2010-10-27 诺和诺德医疗保健公司 凝固因子ⅶ多肽
TW200529870A (en) * 2003-11-20 2005-09-16 Novo Nordisk Healthcare Ag Therapeutic use of factor XI
JP2007520530A (ja) * 2004-02-05 2007-07-26 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 外傷の遅発型合併症の治療のための、ＶＩＩａ因子又はＶＩＩａ因子等価物の使用
WO2006128497A1 (en) * 2005-06-01 2006-12-07 Novo Nordisk A/S Pharmaceutical formulation of factor xi
DK2379096T3 (da) 2008-12-19 2019-11-25 Baxalta GmbH TFPI-inhibitorer og fremgangsmåder til anvendelse
US8450275B2 (en) 2010-03-19 2013-05-28 Baxter International Inc. TFPI inhibitors and methods of use
WO2012045569A1 (en) 2010-10-06 2012-04-12 Medimmune Limited Factor ii and fibrinogen for treatment of haemostatic disorders
HUE046572T2 (hu) 2012-03-21 2020-03-30 Baxalta GmbH TFPI inhibitorok és alkalmazási eljárások
CN105939607A (zh) * 2014-01-31 2016-09-14 达纳-法伯癌症研究所股份有限公司 二氢蝶啶酮衍生物及其用途
EP3307728A4 (en) 2015-06-12 2019-07-17 Dana Farber Cancer Institute, Inc. ASSOCIATION THERAPY USING TRANSCRIPTION INHIBITORS AND KINASE INHIBITORS
EP3380100A4 (en) 2015-11-25 2019-10-02 Dana-Farber Cancer Institute, Inc. BIVALENT BROMODOMAIN INHIBITORS AND USES THEREOF
US11958911B2 (en) 2017-02-10 2024-04-16 Shanghai Benemae Pharmaceutical Anti-coagulation factor XI antibody

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59116213A (ja) * 1982-12-24 1984-07-05 Unitika Ltd エアゾ−ル組成物
JPH0780783B2 (ja) * 1985-11-26 1995-08-30 ノボ ノルディスク アクティーゼルスカブ 出血障害の治療のための第▲ＶＩＩ▼ａ因子を含有する治療組成物
US5580560A (en) * 1989-11-13 1996-12-03 Novo Nordisk A/S Modified factor VII/VIIa
FR2676231A1 (fr) * 1991-05-07 1992-11-13 Aetsrn Concentre de facteur xi de la coagulation sanguine a haute activite specifique, approprie a usage therapeutique et son procede de preparation.
AU2001287550B2 (en) * 2000-09-13 2007-03-22 Novo Nordisk Health Care Ag Human coagulation factor VII variants

Also Published As

Publication number Publication date
CN1304050C (zh) 2007-03-14
JP2004534855A (ja) 2004-11-18
RU2298416C2 (ru) 2007-05-10
MXPA04000415A (es) 2004-11-22
RU2004105031A (ru) 2005-04-20
AU2002354846B2 (en) 2007-08-02
CZ200439A3 (cs) 2005-03-16
CA2452677A1 (en) 2003-01-30
CN1556710A (zh) 2004-12-22
PL369077A1 (en) 2005-04-18
EP1411973A1 (en) 2004-04-28
NO20040235L (no) 2004-03-17
BR0211256A (pt) 2004-07-27
ZA200400012B (en) 2004-08-17
HUP0400976A3 (en) 2006-01-30
WO2003007983A1 (en) 2003-01-30
IL159622A0 (en) 2004-06-01
HUP0400976A2 (hu) 2004-08-30

Similar Documents

Publication Publication Date Title
EP1359936B1 (en) Combined use of factor vii polypeptides and factor viii polypeptides
US7125846B2 (en) Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
US20080058266A1 (en) Pharmaceutical Compositions Comprising Factor VII Polypeptides and Factor XI Polypeptides
US7078479B2 (en) Pharmaceutical composition comprising factor VII polypeptides and alpha2-antiplasmin polypeptides
US20080069810A1 (en) Pharmaceutical Composition Comprising Factor VII Polypeptides and TAFI Polypeptides
US20110059894A1 (en) Factor VII Polypeptides for Preventing Formation of Inhibitors in Subjects with Haemophilia
JP2005526004A (ja) 第ｖｉｉ因子ポリペプチドおよびトラネキサム酸を含む薬学的組成物
US20030203845A1 (en) Combined use of factor VII polypeptides and factor IX polypeptides
KR20040015821A (ko) 인자 ⅶ 폴리펩티드와 인자 ⅹⅰ폴리펩티드를 포함하는약학적 조성물
AU2002354846A1 (en) Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides
JP2006510568A (ja) Ｖｉｉ因子ポリペプチドおよびイプシロン―アミノカプロン酸を含む薬学的組成物
US20080075709A1 (en) Pharmaceutical Composition Comprising Factor VII Polypeptides And Thrombomodulin Polypeptides
AU2002340779B2 (en) Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
AU2002340779A1 (en) Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
JP2005508985A (ja) Ｖｉｉ因子ポリペプチドおよびアプロチニンポリペプチドを含む薬学的組成物
RU2304980C2 (ru) Фармацевтическая композиция, содержащая полипептиды фактора vii и полипептиды pai-1
JP2005510513A (ja) Ｖｉｉ因子ポリペプチドおよびｔａｆｉポリペプチドを含む薬学的組成物
JP2005511601A (ja) 第ｖｉｉ因子ポリペプチドおよび組織プラスミノゲン阻害剤を含む薬学的組成物
JP2005515175A (ja) 第ｖｉｉ因子ポリペプチドおよびアルファ２−抗プラスミンポリペプチドを含む薬学的組成物
JP2005511600A (ja) Ｖｉｉ因子ポリペプチドおよびトロンボモジュリンポリペプチドを含む薬学的組成物

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application